Table 3. Multivariate model for vaccine effectiveness at preventing cases of COVID-19.
Covariates | Odds of having a COVID-19-positive test |
Odds of having a COVID-19-positive test with >= 1 moderate/severe symptom) |
---|---|---|
Adjusted OR (95% CI) | Adjusted OR (95% CI) | |
Vaccination status | ||
Unvaccinated | (ref) | (ref) |
Fully or partially vaccinated | 0.05 (0.04, 0.06) | 0.29 (0.20, 0.40) |
Anxiety | 1.27 (0.96, 1.69) | 1.46 (0.97, 2.21) |
Autoimmune disorder | 1.22 (0.86, 1.74) | 1.15 (0.72, 1.85) |
Blood disorder | 3.01 (1.56, 5.83) | 2.60 (1.28, 5.28) |
Cardiovascular disorder | 0.89 (0.53, 1.50) | 1.47 (0.76, 2.81) |
Depression | 1.00 (0.74, 1.33) | 1.07 (0.71, 1.61) |
Diabetes | 1.23 (0.81, 1.86) | 0.87 (0.48, 1.58) |
Hypertension | 0.89 (0.66, 1.20) | 0.85 (0.55, 1.32) |
Insomnia or trouble sleeping | 1.09 (0.84, 1.42) | 1.57 (1.09, 2.25) |
Kidney Disorder | 1.19 (0.60, 2.36) | 0.95 (0.38, 2.42) |
Lung Disorder | 0.55 (0.37, 0.81) | 0.90 (0.54, 1.52) |
Education | ||
Some college or less | (ref) | (ref) |
4-year college degree | 0.73 (0.55, 0.97) | 0.71 (0.46, 1.08) |
>4-year college degree | 0.97 (0.74, 1.27) | 0.68 (0.45, 1.02) |
Race | ||
Other | (ref) | (ref) |
White | 2.33 (1.64, 3.32) | 1.09 (0.65, 1.82) |
Age (per 1 year increment) | 1.00 (0.99, 1.01) | 1.01 (0.99, 1.02) |
Gender | ||
Female | (ref) | (ref) |
Male | 1.50 (1.10, 2.06) | 1.26 (0.79, 2.01) |
Other | 1.35 (0.63, 2.91) | 1.29 (0.48, 3.47) |
Ethnicity (Hispanic Latino vs not) | ||
Not Hispanic | (ref) | (ref) |
Hispanic | 0.99 (0.68, 1.46) | 0.84 (0.45, 1.54) |
Vaccination access (proxy) | ||
Early availability, high vaccination rate | (ref) | (ref) |
Early availability, low vaccination rate | 0.87 (0.60, 1.26) | 1.24 (0.74, 2.09) |
Late availability, high vaccination rate | 0.63 (0.46, 0.86) | 0.72 (0.44, 1.16) |
Late availability, low vaccination rate | 1.15 (0.83, 1.60) | 1.26 (0.79, 2.02) |
If a referent category is not listed, then the comparison is yes vs no (referent group).